Previous 10 | Next 10 |
2024-04-16 22:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-07 01:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting Data will be featured in an encore presentation at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) ...
2024-03-18 02:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-16 07:55:32 ET Summary Longboard Pharmaceuticals has seen a significant increase in its stock price following positive data from its Phase 1b/2a study of bexicaserin, a treatment for developmental and epileptic encephalopathies. The company plans to initiate a Phase 3 stud...
2024-03-12 17:04:48 ET More on Longboard Pharmaceuticals Behind The Huge Rally In Longboard Pharmaceuticals Longboard Pharma: Excellent Data In Epileptic Seizures, But We Are A Little Late Now Longboard stock up 8% as Citi initiates at buy, citing takeover potential ...
2024-03-12 16:58:39 ET More on Longboard Pharmaceuticals Behind The Huge Rally In Longboard Pharmaceuticals Longboard Pharma: Excellent Data In Epileptic Seizures, But We Are A Little Late Now Longboard stock up 8% as Citi initiates at buy, citing takeover potential ...
Bexicaserin (LP352) Phase 1b/2a PACIFIC Study positive topline data in participants with Developmental and Epileptic Encephalopathies (DEEs) was reported in January Announcing an update to the primary efficacy endpoint data previously reported in January, which show further improvement in...
2024-03-08 03:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
News, Short Squeeze, Breakout and More Instantly...
Longboard Pharmaceuticals Inc. Company Name:
LBPH Stock Symbol:
NASDAQ Market:
Longboard Pharmaceuticals Inc. Website:
2024-07-16 13:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-06 15:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-02 10:45:05 ET Ford Motor Co. (F) F is trading UP for the last 5 days, and it at trading at $12.82 with volume of 15,047,573 and a one day change of $0.06 (0.47%). Ford Motor Co. has a 52-week low of 9.63 and a 52-week high of $15.42. The business's 50-day moving average pri...